KPMA’s emergency committee striving to publicize contributing roles of local pharmaceutical firms

The pharmaceutical industry has never really had a good reputation, either here or elsewhere. Behind the life-curing business are heavy lobbying, dirty politics and giant rebates for favorite buyers, all of which is reflected in today's public distrust.

To make the matters worse, the government’s new pricing reform to eradicate illegal rebate will reduce the market share of domestic generic ...